Skip to main content

Table 2 Hazard ratios and 95% confidence intervals (CIs) of PAD by quartiles of FPG variability (CV, SD, and VIM)

From: Implications of fasting plasma glucose variability on the risk of incident peripheral artery disease in a population without diabetes: a nationwide population-based cohort study

 

N

Events (n)

Follow-up duration (person-years)

Hazard ratio (95% CI)

Unadjusted

Model 1

Model 2

Model 3

Model 4

FPG variability (CV)

 Q1

38,246

4162

298,563

1

1

1

1

1

 Q2

38,219

3898

299,318

0.94 (0.90, 0.98)

1.01 (0.96, 1.05)

1.00 (0.96, 1.05)

1.00 (0.95, 1.04)

1.00 (0.95, 1.04)

 Q3

38,231

4171

297,885

1.01 (0.96, 1.05)

1.08 (1.04, 1.13)

1.07 (1.03, 1.12)

1.07 (1.02, 1.12)

1.07 (1.02, 1.12)

 Q4

38,235

4632

293,916

1.13 (1.08, 1.18)

1.15 (1.11, 1.20)

1.14 (1.09, 1.19)

1.12 (1.07, 1.17)

1.11 (1.07, 1.16)

P for trend

  

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

FPG variability (SD)

 Q1

38,234

4119

298,809

1

1

1

1

1

 Q2

38,306

3944

299,810

0.96 (0.91, 1.00)

1.02 (0.98, 1.07)

1.02 (0.97, 1.06)

1.01 (0.97, 1.06)

1.01 (0.97, 1.06)

 Q3

38,157

4119

297,664

1.00 (0.96, 1.05)

1.08 (1.03, 1.13)

1.07 (1.02, 1.11)

1.05 (1.01, 1.10)

1.05 (1.01, 1.10)

 Q4

38,234

4681

293,400

1.16 (1.11, 1.21)

1.18 (1.13, 1.23)

1.15 (1.11, 1.20)

1.12 (1.07, 1.17)

1.11 (1.06, 1.16)

P for trend

  

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

FPG variability (VIM)

 Q1

38,232

4196

298,180

1

1

1

1

1

 Q2

38,233

3970

298,826

0.95 (0.91, 0.99)

1.01 (0.97, 1.06)

1.01 (0.97, 1.05)

1.00 (0.96, 1.05)

1.01 (0.96, 1.05)

 Q3

38,233

4132

298,022

0.99 (0.94, 1.03)

1.07 (1.02, 1.12)

1.07 (1.02, 1.11)

1.07 (1.02, 1.11)

1.07 (1.03, 1.12)

 Q4

38,233

4565

294,654

1.10 (1.06, 1.15)

1.13 (1.08, 1.18)

1.13 (1.08, 1.17)

1.11 (1.07, 1.16)

1.11 (1.07, 1.16)

P for trend

  

< 0.001

< 0.001

< 0.001

< 0.001

<  0.001

  1. Model 1: Adjusted for age and sex
  2. Model 2: Model 1+ body mass index, smoking status, alcohol consumption, regular exercise, and income
  3. Model 3: Model 2+ antihypertensive medications, dyslipidemia medications, systolic blood pressure, total cholesterol, history of stroke, history of coronary artery disease, and history of chronic kidney disease
  4. Model 4: Model 3 + mean FPG
  5. PAD: peripheral artery disease; FPG: fasting plasma glucose; CV: coefficient of variation; SD: standard deviation; VIM: variability independent of the mean